Cover Story

Despite promising new regimens, search for cure is ‘highest priority’ in advanced renal cell carcinoma

HemOnc Today, June 25, 2019
With approximately 73,820 diagnoses and 14,770 deaths expected this year in the U.S., renal cell carcinoma remains a cancer in need of new treatment…
Molecular Oncology

Therapeutic armamentarium in urothelial carcinoma grows with understanding of tumor biology

HemOnc Today, June 10, 2019
Petros Grivas, MD, PhD
Bladder cancer is one of the most common forms of cancer in United States, with an estimated 81,190 new cases and 17,240 deaths in 2018. Urothelial…
Point/Counter

Will new therapies for sickle cell disease lead to a change or reduction in use of hydroxyurea for the management of pain?

HemOnc Today, June 10, 2019
POINT Over the last 20 years, strong and consistent evidence has demonstrated when children and adults with sickle cell disease are adherent to…
Cover Story

Sickle cell disease poised for ‘golden age of treatment’ amid progress toward cure

HemOnc Today, June 10, 2019
As researchers work to expand curable approaches for sickle cell disease, new options for managing its acute and chronic complications appear within…
Feature

As Trump administration considers importing drugs from Canada, experts analyze risks, benefits

June 4, 2019
The idea of importing prescription drugs from Canada as a means to lower prices is back under scrutiny with President Donald J. Trump verbally…
Meeting News

CAR T-cell therapy total cost can exceed $1.5 million per treatment

May 29, 2019
PHILADELPHIA — When factoring in all the costs associated with chimeric antigen receptor T-cell therapy, hospitals may charge as much as $1.5…
Feature

Experts divided regarding impact from Trump’s plan to put drug prices in TV ads

May 29, 2019
HHS recently enacted one of the first concrete steps toward President Donald J. Trump’s pledge to lower drug prices in finalizing a federal…
Feature

‘Platelet decoys’ may lower blood clot risk, prevent cancer metastasis

May 28, 2019
A novel antiplatelet therapy showed potential in reducing blood clot risk and preventing cancer metastasis, according to preclinical research…
In the JournalsPerspective

New CAR T-cell Therapy Shows No Severe Toxic Side Effects

Cell Therapy Next, May 2019
A novel version of CAR T-cell therapy has shown no severe toxic side effects in patients with recurrent lymphoma, according to a study published in…
Cover Story

‘A Moment of Marvel’ in Manhattan Brings a Revolution in CAR T-Cell Therapy

Cell Therapy Next, May 2019
When the first flow cytometry analysis was run after a CAR T-cell therapy, showing no evidence of leukemia, Michel Sadelain, MD, PhD, and Isabelle